Mercantile Court in Spain Rules in ZELTIQ® Aesthetics Patent Infringement Lawsuit Against Clinipro  
1/30/2013 10:06:53 AM

PLEASANTON, Calif.--(BUSINESS WIRE)--ZELTIQ® Aesthetics, Inc. (Nasdaq: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that the Mercantile Court in Spain rendered its ruling on the merits of ZELTIQ’s and Massachusetts General Hospital’s (MGH) request for a permanent injunction against Clinipro’s LipoCryo device based on Clinipro’s infringement of two European patents owned by MGH and globally licensed exclusively to ZELTIQ and denied the request.